Belgium · Series D startup
4 rounds we have observed, with the 8 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$115Mraised across 4 rounds since 2010, from 4 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
From a historical funding record
Reported by finsmes.com
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
EQT life scienceBoehringer Ingelheim Venture Fund
Mitsui Global Investment
ITOCHU Corporation
S.R.I.W.
ShireShinsei Capital PartnersMissing a round, or an investor who was in one? Tell us.
Promethera Biosciences's investors include EQT life science, Boehringer Ingelheim Venture Fund, Mitsui Global Investment, ITOCHU Corporation and S.R.I.W., and 3 more on record.
Promethera Biosciences has raised $115M across 4 rounds since 2010.
Promethera Biosciences's most recent round was a Series D of $44M in May 2019.
Its most recent round, $44M in May 2019, is also its largest on record.
Promethera Biosciences's first round on record, in Feb 2010, was backed by EQT life science, S.R.I.W. and Vesalius Biocapital Partners.
Promethera Biosciences's latest named round is a Series D, in May 2019.
Promethera Biosciences is based in Belgium.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
Belgium · 
